检索结果 - Law, Steven
- Showing 1 - 8 results of 8
-
1
-
2
Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplan... 由 Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
出版 2020Text -
3
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis 由 Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
出版 2022Text -
4
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib 由 Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.
出版 2021Text -
5
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis 由 Cohen, Oliver C., Law, Steven, Lachmann, Helen J., Sharpley, Faye, Ravichandran, Sriram, Mahmood, Shameem, Sachchithanantham, Sajitha, Whelan, Carol J., De Azcona Naharro, Ana Martinez, Fontana, Marianna, Hawkins, Philip N., Gillmore, Julian D., Wechalekar, Ashutosh D.
出版 2020Text -
6
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage 由 Law, Steven, Petrie, Aviva, Chacko, Liza, Cohen, Oliver C., Ravichandran, Sriram, Gilbertson, Janet A., Rowczenio, Dorota, Wechalekar, Ashutosh, Martinez‐Naharro, Ana, Lachmann, Helen J., Whelan, Carol J., Hutt, David F., Hawkins, Philip N., Fontana, Marianna, Gillmore, Julian D.
出版 2020Text -
7
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy 由 Law, Steven, Petrie, Aviva, Chacko, Liza, Cohen, Oliver C, Ravichandran, Sriram, Gilbertson, Janet A, Rowczenio, Dorota, Wechalekar, Ashutosh D, Martinez-Naharro, Ana, Lachmann, Helen J, Whelan, Carol J, Hutt, David F, Hawkins, Philip N, Fontana, Marianna, Gillmore, Julian D
出版 2022Text -
8
Characteristics and natural history of early-stage cardiac transthyretin amyloidosis 由 Law, Steven, Bezard, Melanie, Petrie, Aviva, Chacko, Liza, Cohen, Oliver C, Ravichandran, Sriram, Ogunbiyi, Olabisi, Kharoubi, Mounira, Ganeshananthan, Sashiananthan, Ganeshananthan, Sharmananthan, Gilbertson, Janet A, Rowczenio, Dorota, Wechalekar, Ashutosh, Martinez-Naharro, Ana, Lachmann, Helen J, Whelan, Carol J, Hutt, David F, Hawkins, Philip N, Damy, Thibaud, Fontana, Marianna, Gillmore, Julian D
出版 2022Text